Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 729 clinical trials
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma

The study aims to evaluate the safety and preliminary efficacy of the combination of cabozantinib and pembrolizumab in advanced melanoma

  • 0 views
  • 12 Apr, 2021
  • 1 location
FHD-286 in Subjects With Metastatic Uveal Melanoma

activity of FHD-286 oral monotherapy in subjects with metastatic Uveal Melanoma (UM).

  • 0 views
  • 16 May, 2021
  • 9 locations
Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma

target volume (PTV) in patients with uveal melanoma. Patients will be followed-up for 10 years after radiotherapy regarding local tumor control, visual acuity, secondary complications and survival.

conservative treatment
  • 9 views
  • 07 Nov, 2020
  • 1 location
Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

This is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma. Ipilimumab (1 mg/kg) and Nivolumab (3 mg/kg) will be administered Day 1 of a

  • 49 views
  • 18 Apr, 2021
  • 7 locations
Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Patients suffering from uveal melanoma (typed positive for monosomy 3 and without evidence for metastases) will be vaccinated over a period of 2 years with Dendritic Cell loaded with autologous

metastasis
therapeutic autologous dendritic cells
  • 16 views
  • 09 May, 2021
  • 12 locations
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

This is an investigator-initiated Phase I study of a single dose of an intravitreally-administered dexamethasone implant (Ozurdex) in subjects with uveal melanomas (UM) and exudative retinal

  • 0 views
  • 24 Jan, 2021
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

with metastatic melanoma that failed immunotherapy.Tumor-infiltrating lymphocytes will be expanded from resected melanoma samples from the patient and expanded TILs will be transferred to the patient

liver metastasis
neutrophil count
metastasis
gilbert's syndrome
measurable disease
  • 0 views
  • 25 Jan, 2021
  • 1 location
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

The purpose of this research is to test if a combination treatment of nivolumab and relatlimab will result in tumor reduction in patients with metastatic uveal melanoma.

  • 0 views
  • 09 May, 2021
  • 2 locations
Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study

for lenvatinib) as first-line treatment in Chinese participants with no prior systemic therapy for their advanced melanoma.

cancer
cytotoxic t-lymphocyte antigen 4
immunologic adjuvant
mk-3475
targeted therapy
  • 0 views
  • 16 Jun, 2021
  • 8 locations
Adjuvant Nivolumab Treatment in Stage II (IIA IIB IIC) High-risk Melanoma

. However, to subdivide stage II melanoma patients into having a low or high risk for relapse further methods are needed. This clinical trial will evaluate whether adjuvant nivolumab treatment will

  • 0 views
  • 23 Feb, 2021
  • 22 locations